杏林製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/05/31 | 1,889 | 1,917 | 1,888 | 1,897 | -5 | -0.3% | 215,300 |
2019/05/30 | 1,929 | 1,935 | 1,883 | 1,902 | -46 | -2.4% | 175,400 |
2019/05/29 | 1,905 | 1,960 | 1,893 | 1,948 | +6 | +0.3% | 313,900 |
2019/05/28 | 1,956 | 1,957 | 1,931 | 1,942 | -23 | -1.2% | 287,500 |
2019/05/27 | 1,973 | 1,975 | 1,958 | 1,965 | -8 | -0.4% | 91,400 |
2019/05/24 | 1,971 | 1,986 | 1,957 | 1,973 | +17 | +0.9% | 145,400 |
2019/05/23 | 1,934 | 1,963 | 1,934 | 1,956 | +18 | +0.9% | 189,500 |
2019/05/22 | 1,960 | 1,962 | 1,920 | 1,938 | -2 | -0.1% | 235,200 |
2019/05/21 | 1,922 | 1,960 | 1,913 | 1,940 | +20 | +1% | 178,500 |
2019/05/20 | 1,944 | 1,953 | 1,911 | 1,920 | -27 | -1.4% | 131,200 |
2019/05/17 | 1,907 | 1,949 | 1,896 | 1,947 | +77 | +4.1% | 287,300 |
2019/05/16 | 1,938 | 1,941 | 1,861 | 1,870 | -64 | -3.3% | 373,300 |
2019/05/15 | 2,002 | 2,005 | 1,911 | 1,934 | -52 | -2.6% | 299,300 |
2019/05/14 | 2,000 | 2,021 | 1,950 | 1,986 | -34 | -1.7% | 344,800 |
2019/05/13 | 2,061 | 2,093 | 2,018 | 2,020 | -48 | -2.3% | 237,600 |
2019/05/10 | 2,039 | 2,111 | 2,039 | 2,068 | +29 | +1.4% | 230,200 |
2019/05/09 | 2,043 | 2,059 | 2,020 | 2,039 | -19 | -0.9% | 248,700 |
2019/05/08 | 2,054 | 2,082 | 2,044 | 2,058 | -35 | -1.7% | 148,800 |
2019/05/07 | 2,057 | 2,103 | 2,053 | 2,093 | +7 | +0.3% | 178,500 |
2019/04/26 | 2,073 | 2,091 | 2,070 | 2,086 | +13 | +0.6% | 150,200 |
2019/04/25 | 2,053 | 2,078 | 2,037 | 2,073 | +30 | +1.5% | 171,900 |
2019/04/24 | 2,080 | 2,088 | 2,043 | 2,043 | -14 | -0.7% | 131,900 |
2019/04/23 | 2,034 | 2,060 | 2,034 | 2,057 | +17 | +0.8% | 155,800 |
2019/04/22 | 2,016 | 2,040 | 2,005 | 2,040 | +14 | +0.7% | 87,500 |
2019/04/19 | 2,045 | 2,045 | 2,009 | 2,026 | -4 | -0.2% | 104,200 |
2019/04/18 | 2,075 | 2,080 | 2,023 | 2,030 | -72 | -3.4% | 192,400 |
2019/04/17 | 2,070 | 2,111 | 2,058 | 2,102 | +37 | +1.8% | 225,800 |
2019/04/16 | 2,060 | 2,085 | 2,054 | 2,065 | -1 | ±0% | 107,800 |
2019/04/15 | 2,083 | 2,083 | 2,058 | 2,066 | +15 | +0.7% | 105,300 |
2019/04/12 | 2,080 | 2,080 | 2,044 | 2,051 | -28 | -1.3% | 134,400 |
2019/04/11 | 2,082 | 2,096 | 2,065 | 2,079 | -8 | -0.4% | 149,800 |
2019/04/10 | 2,097 | 2,102 | 2,080 | 2,087 | -43 | -2% | 151,000 |
2019/04/09 | 2,133 | 2,147 | 2,110 | 2,130 | -10 | -0.5% | 88,800 |
2019/04/08 | 2,158 | 2,165 | 2,134 | 2,140 | -18 | -0.8% | 89,000 |
2019/04/05 | 2,180 | 2,185 | 2,155 | 2,158 | -26 | -1.2% | 121,900 |
2019/04/04 | 2,182 | 2,199 | 2,176 | 2,184 | -18 | -0.8% | 64,400 |
2019/04/03 | 2,171 | 2,211 | 2,168 | 2,202 | +9 | +0.4% | 120,300 |
2019/04/02 | 2,219 | 2,227 | 2,190 | 2,193 | -9 | -0.4% | 193,500 |
2019/04/01 | 2,214 | 2,240 | 2,200 | 2,202 | +41 | +1.9% | 169,200 |
2019/03/29 | 2,140 | 2,177 | 2,133 | 2,161 | +25 | +1.2% | 139,500 |
2019/03/28 | 2,164 | 2,170 | 2,122 | 2,136 | -74 | -3.3% | 146,200 |
2019/03/27 | 2,228 | 2,249 | 2,195 | 2,210 | -42 | -1.9% | 242,800 |
2019/03/26 | 2,153 | 2,255 | 2,150 | 2,252 | +144 | +6.8% | 350,700 |
2019/03/25 | 2,172 | 2,173 | 2,099 | 2,108 | -62 | -2.9% | 231,400 |
2019/03/22 | 2,205 | 2,206 | 2,152 | 2,170 | -46 | -2.1% | 304,800 |
2019/03/20 | 2,212 | 2,217 | 2,194 | 2,216 | +9 | +0.4% | 196,600 |
2019/03/19 | 2,214 | 2,219 | 2,196 | 2,207 | -7 | -0.3% | 169,900 |
2019/03/18 | 2,226 | 2,227 | 2,201 | 2,214 | +19 | +0.9% | 157,800 |
2019/03/15 | 2,207 | 2,226 | 2,195 | 2,195 | +3 | +0.1% | 227,400 |
2019/03/14 | 2,230 | 2,234 | 2,192 | 2,192 | -25 | -1.1% | 112,100 |
1451~
1500
件表示中 / 3695件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
杏林製薬 | 148,800円 | +8.8% | +99.9% | 3.49% | 9.50倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ゼリア新薬 | 217,600円 | +3.1% | -6.5% | 2.21% | 10.10倍 | 1.07倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
持田薬 | 309,500円 | +3.0% | +27.5% | 2.58% | 19.59倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
栄研化 | 223,000円 | +0.4% | -8.4% | 2.38% | 28.63倍 | 1.60倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ネクセラファーマ | 87,600円 | +20.3% | - | 0.00% | 154.50倍 | 1.15倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム